IPOs and Secondaries

IPOs and Secondaries Articles

TPI Composites intends to sell more than 4 million shares in a secondary offering valued up to more than $101 million.
Now that its quiet period is over, analysts are taking the opportunity to weigh in on Schneider National, and many are calling for the stock to go higher.
Milacron intends to offer 12 million shares in a secondary offering valued up to almost $260 million.
Following a week that saw 9 successful IPOs, the coming week will see another 6 firms take aim at the US public equity markets.
Big data platform provider Cloudera raised $225 million in a Friday morning IPO that valued the company at more than $2 billion. Intel's stake of around 25 million shares is now worth about half what...
Carvana expects to price 15 million shares in the range of $14 to $16 in and initial public offering valued up to about $276 million.
Dole Food has filed with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO).
WideOpenWest has amended its filing with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO).
The world’s leading independent internet television network has been able to raise capital over time, and now the company is out with another large capital raise.
The eight IPOs on next week's calendar include big-data platform provider Cloudera and online used car seller Carvana. One Chinese peer-to-peer lender is also going to test the market.
Veritone expects to price more than a million shares in the range of $14 to $16 apiece for an initial public offering valued up to $23 million.
Bright Scholar Education has filed an F-1 form with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO).
Shares of Edge Therapeutics posted a solid gain in Wednesday’s trading session after the company announced that it would be conducting a registered direct offering of its common stock.
Audentes Therapeutics saw its shares drop early on Wednesday after the company announced the pricing of its secondary offering.
Arena Pharmaceuticals saw its shares drop sharply on Tuesday after the company announced a secondary offering of 60 million shares of its common stock.